急性呼吸窘迫综合征:诊断与治疗进展
该综述检索2012至2017年MEDLINE、EMBASE和Cochrane系统评价数据库,筛选1662篇文献后纳入31篇关于ARDS诊断或治疗重大进展的文章。柏林定义根据低氧血症严重程度提出3类ARDS:轻度(200 mm Hg<Pao2/FiO2≤300 mm Hg)、中度(100 mm Hg<Pao2/FiO2≤200 mm Hg)、重度(Pao2/Fio2≤100 mm Hg),并明确发病时间、水肿起源和胸部影像学表现的标准;柏林定义对死亡的预测效度显著优于既往欧美共识会议定义。管理核心仍是机械通气以尽量减少呼吸机所致肺损伤(VILI);阿司匹林未能预防高危患者发生ARDS;对PaO2/FiO2比值低于150 mm Hg者进行俯卧位通气与显著死亡获益相关,而体外二氧化碳去除等其他辅助干预仍属实验性;β2受体激动剂、他汀类药物和角质细胞生长因子等药物治疗无益且显示可能有害。近期ARDS机械通气指南对6项干预措施给出循证推荐。
要点
- 柏林定义按Pao2/FiO2将ARDS分为轻度(200 mm Hg<Pao2/FiO2≤300 mm Hg)、中度(100 mm Hg<Pao2/FiO2≤200 mm Hg)和重度(Pao2/Fio2≤100 mm Hg)。
- 柏林定义对死亡的预测效度显著优于既往欧美共识会议定义,但临床医生对水肿起源和胸部影像学标准的判读可靠性可能较低。
- 对PaO2/FiO2比值低于150 mm Hg的ARDS患者行俯卧位通气与显著死亡获益相关。
- β2受体激动剂、他汀类药物和角质细胞生长因子等药物治疗无益且显示可能有害。
- 阿司匹林未能预防高危患者发生ARDS。
适用人群与场景
- 美国每年约200 000例ARDS患者,其中每年近75 000例死亡;全球ARDS占ICU入院的10%,每年超过300万例。
- 柏林定义根据低氧血症严重程度将ARDS分为轻度(200 mm Hg<Pao2/FiO2≤300 mm Hg)、中度(100 mm Hg<Pao2/FiO2≤200 mm Hg)和重度(Pao2/Fio2≤100 mm Hg)。
诊断标准与关键阈值
- 柏林定义:根据低氧血症严重程度分为轻度(200 mm Hg<Pao2/FiO2≤300 mm Hg)、中度(100 mm Hg<Pao2/FiO2≤200 mm Hg)、重度(Pao2/Fio2≤100 mm Hg),并明确发病时间、水肿起源和胸部影像学表现的相关标准。
处置流程与药物剂量
- 管理核心仍是机械通气,目标是尽量减少呼吸机所致肺损伤(VILI)。
- 对PaO2/FiO2比值低于150 mm Hg的患者行俯卧位通气与显著死亡获益相关。
- 体外二氧化碳去除等其他辅助干预仍属实验性。
- 近期ARDS机械通气指南对6项干预措施给出循证推荐,包括低潮气量和吸气压力通气、俯卧位通气、高频振荡通气、较高与较低呼气末正压、肺复张操作和体外膜氧合。
研究设计与关键结果
- 该综述检索MEDLINE、EMBASE和Cochrane系统评价数据库2012至2017年文献,筛选1662篇后纳入31篇关于ARDS诊断或治疗重大进展的文章。
- 柏林定义对死亡的预测效度显著优于既往欧美共识会议定义。
- 临床医生对水肿起源和胸部影像学标准的判读可靠性可能较低,可能导致ARDS识别不足。
- 阿司匹林未能预防高危患者发生ARDS。
- 对PaO2/FiO2比值低于150 mm Hg的患者行俯卧位通气与显著死亡获益相关。
- β2受体激动剂、他汀类药物和角质细胞生长因子等药物治疗无益且显示可能有害。
证据类型、等级与局限
- 证据类型:综述,检索2012至2017年随机临床试验、Meta分析、系统评价和临床实践指南。
- 局限:原文未报告局限性。
对床旁实践的改变
- 柏林定义对死亡的预测效度显著优于既往欧美共识会议定义,但临床医生对水肿起源和胸部影像学标准的判读可靠性可能较低,可能导致ARDS识别不足。
- 管理仍以肺保护性机械通气为核心,目标是尽量减少VILI。
- 对PaO2/FiO2比值低于150 mm Hg的ARDS患者,俯卧位通气与显著死亡获益相关。
- β2受体激动剂、他汀类药物和角质细胞生长因子等药物治疗无益且显示可能有害。
- 阿司匹林未能预防高危患者发生ARDS。
- 近期ARDS机械通气指南对6项干预措施给出循证推荐,可帮助临床医生实施循证干预以可能改善预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Acute respiratory distress syndrome (ARDS) is a life-threatening form of respiratory failure that affects approximately 200 000 patients each year in the United States, resulting in nearly 75 000 deaths annually. Globally, ARDS accounts for 10% of intensive care unit admissions, representing more than 3 million patients with ARDS annually.
OBJECTIVE: To review advances in diagnosis and treatment of ARDS over the last 5 years.
EVIDENCE REVIEW: We searched MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews from 2012 to 2017 focusing on randomized clinical trials, meta-analyses, systematic reviews, and clinical practice guidelines. Articles were identified for full text review with manual review of bibliographies generating additional references.
FINDINGS: After screening 1662 citations, 31 articles detailing major advances in the diagnosis or treatment of ARDS were selected. The Berlin definition proposed 3 categories of ARDS based on the severity of hypoxemia: mild (200 mm Hg<Pao2/Fio2≤300 mm Hg), moderate (100 mm Hg<Pao2/Fio2≤200 mm Hg), and severe (Pao2/Fio2 ≤100 mm Hg), along with explicit criteria related to timing of the syndrome's onset, origin of edema, and the chest radiograph findings. The Berlin definition has significantly greater predictive validity for mortality than the prior American-European Consensus Conference definition. Clinician interpretation of the origin of edema and chest radiograph criteria may be less reliable in making a diagnosis of ARDS. The cornerstone of management remains mechanical ventilation, with a goal to minimize ventilator-induced lung injury (VILI). Aspirin was not effective in preventing ARDS in patients at high-risk for the syndrome. Adjunctive interventions to further minimize VILI, such as prone positioning in patients with a Pao2/Fio2 ratio less than 150 mm Hg, were associated with a significant mortality benefit whereas others (eg, extracorporeal carbon dioxide removal) remain experimental. Pharmacologic therapies such as β2 agonists, statins, and keratinocyte growth factor, which targeted pathophysiologic alterations in ARDS, were not beneficial and demonstrated possible harm. Recent guidelines on mechanical ventilation in ARDS provide evidence-based recommendations related to 6 interventions, including low tidal volume and inspiratory pressure ventilation, prone positioning, high-frequency oscillatory ventilation, higher vs lower positive end-expiratory pressure, lung recruitment maneuvers, and extracorporeal membrane oxygenation.
CONCLUSIONS AND RELEVANCE: The Berlin definition of acute respiratory distress syndrome addressed limitations of the American-European Consensus Conference definition, but poor reliability of some criteria may contribute to underrecognition by clinicians. No pharmacologic treatments aimed at the underlying pathology have been shown to be effective, and management remains supportive with lung-protective mechanical ventilation. Guidelines on mechanical ventilation in patients with acute respiratory distress syndrome can assist clinicians in delivering evidence-based interventions that may lead to improved outcomes.
参考来源
- Fan E, Brodie D, Slutsky AS, et al. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. JAMA. 2018. PMID: 29466596. doi:10.1001/jama.2017.21907
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。